Options
A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis
Fecha de emisión
2019
Autor(es)
Herrera M.I.
Kölliker-Frers R.A.
Otero-Losada M.
Perez Lloret S.
Filippo M.
Tau J.
Capani, Francisco
Villa A.M.
DOI
10.3389/fneur.2019.01046
Temas
biomarker potential
cytokines
disability progressio...
expanded disability s...
neurofilament heavy c...
relapsing-remitting m...
cytokine
intercellular adhesio...
interleukin 17
interleukin 1beta
interleukin 6
interleukin 8
monocyte chemotactic ...
neurofilament H prote...
neurofilament protein...
transforming growth f...
tumor necrosis factor...
unclassified drug
adult
Article
axonal injury
case study
clinical article
clinical evaluation
controlled study
correlational study
cross-sectional study...
deterioration
disease exacerbation
disease marker
enzyme linked immunos...
Expanded Disability S...
feasibility study
female
human
immunomodulation
male
metabolic disorder
multiple sclerosis
observational study
pilot study
protein blood level
protein phosphorylati...
scoring system